Article: NAK Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Northern Dynasty Minerals Ltd. (NYSE: NAK); Lead Plaintiff Deadline is February 2, 2021

Article - Media, Publications

NAK Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Northern Dynasty Minerals Ltd. (NYSE: NAK); Lead Plaintiff Deadline is February 2, 2021

PRNewswire, 05 January 2021

Berger Montague is investigating potential securities fraud claims against Northern Dynasty Minerals Ltd. (“Northern Dynasty” or the “Company”) on behalf of investors who purchased Northern Dynasty securities (NYSE: NAK) between December 21, 2017 and November 25, 2020 (the “Class Period”).

A recently filed lawsuit accuses Northern Dynasty and its senior management of misleading investors about the Company’s proposed Pebble Project, a large mining project in Alaska, and its prospects for securing a permit from federal and state regulators. Northern Dynasty repeatedly touted its progress in obtaining the necessary permits for the Pebble Project and assured investors that its design entailed a substantially reduced development footprint and new environmental safeguards for the mine.
Continue reading “Article: NAK Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Northern Dynasty Minerals Ltd. (NYSE: NAK); Lead Plaintiff Deadline is February 2, 2021”

Article: LOOP Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Loop Industries, Inc. (LOOP); Lead Plaintiff Deadline is December 14, 2020

Article - Media, Publications

LOOP Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Loop Industries, Inc. (LOOP); Lead Plaintiff Deadline is December 14, 2020

Newsfile, 03 November 2020

Berger Montague is investigating potential securities fraud claims against Loop Industries, Inc. (NASDAQ: LOOP) (“Loop” or the “Company”) on behalf of investors who purchased Loop securities between September 24, 2018 and October 12, 2020 (the “Class Period”). If you purchased Loop securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague’s investigation, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Donnell Much at dmuch@bm.net or (215) 875-4667, or contact us at www.bergermontague.com/loop-industries.
Continue reading “Article: LOOP Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Loop Industries, Inc. (LOOP); Lead Plaintiff Deadline is December 14, 2020”

Article: Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PharmaCielo Ltd. (PCLOF) on Behalf of Investors

Article - Media, Publications

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PharmaCielo Ltd. (PCLOF) on Behalf of Investors

BUSINESS WIRE, 04 March 2020

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf PharmaCielo Ltd. (“PharmaCielo” or “the Company”) (OTC: PCLOF) investors concerning the Company and its officers’ possible violations of the federal securities laws.

On March 2, 2020, Hindenburg Research published a report, alleging, among other things, that PharmaCielo’s “key operating property in Rionegro, Colombia” was sold “at a massive markup, allowing insiders to enrich themselves by an estimated $5.35 million.” The report also stated that the Company’s purported greenhouse facilities on newly-purchased land is “nothing more than an empty field covered in weeds.”
Continue reading “Article: Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PharmaCielo Ltd. (PCLOF) on Behalf of Investors”

Article: Nymox Pharmaceutical Corporation Investigated For Securities Fraud By Block & Leviton After Report Reveals Pervasive Misconduct By The Company

Article - Media, Publications

Nymox Pharmaceutical Corporation Investigated For Securities Fraud By Block & Leviton After Report Reveals Pervasive Misconduct By The Company

PRNewswire, 11 August 2016

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Nymox Pharmaceutical Corporation (“Nymox” or the “Company”) (NASDAQ: NYMX) and certain of its officers and directors violated federal securities laws.

Nymox shares plummeted nearly 41% on August 10, 2016, after an article titled “Nymox: This Offshore ‘Biotech’ Promotion Will Go To Zero (Yes, Zero)” was published on the investment research site Seeking Alpha, reporting that Nymox has and continues to mislead shareholders about the Company’s prospects, while “dumping millions in stock without making timely SEC disclosures.” The revelation of Nymox’s fraudulent conduct has caused tens of millions in losses to Nymox investors.
Continue reading “Article: Nymox Pharmaceutical Corporation Investigated For Securities Fraud By Block & Leviton After Report Reveals Pervasive Misconduct By The Company”